PRICE T ROWE ASSOCIATES INC /MD/ - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 1 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$69
-9.2%
59,900
-27.7%
0.00%
Q2 2023$76
+26.7%
82,800
-21.5%
0.00%
Q1 2023$60
-37.5%
105,500
-36.8%
0.00%
Q4 2022$96
-99.8%
166,9000.0%0.00%
Q3 2022$54,000
+217.6%
166,900
+254.4%
0.00%
Q2 2022$17,000
-62.2%
47,100
-24.8%
0.00%
Q1 2022$45,000
-55.0%
62,607
+40.8%
0.00%
Q4 2021$100,000
-27.0%
44,458
-6.5%
0.00%
Q3 2021$137,000
-21.3%
47,558
+3.3%
0.00%
Q2 2021$174,000
+20.8%
46,023
+7.8%
0.00%
Q1 2021$144,000
+20.0%
42,674
-0.2%
0.00%
Q4 2020$120,000
+30.4%
42,743
+16.8%
0.00%
Q3 2020$92,000
-75.5%
36,597
+32.6%
0.00%
Q2 2020$375,000
+87.5%
27,597
+4.6%
0.00%
Q1 2020$200,000
+23.5%
26,392
+2.9%
0.00%
Q4 2019$162,000
+95.2%
25,652
+21.7%
0.00%
Q3 2019$83,000
-16.2%
21,074
+3.2%
0.00%
Q2 2019$99,000
-38.1%
20,423
+4.3%
0.00%
Q1 2019$160,000
+49.5%
19,577
+1.0%
0.00%
Q4 2018$107,000
-46.2%
19,377
-14.2%
0.00%
Q3 2018$199,000
-10.4%
22,590
+1.3%
0.00%
Q2 2018$222,000
+5.2%
22,293
+0.5%
0.00%
Q1 2018$211,00022,1860.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Novo Holdings A/S 3,100,000$15,004,0002.10%
DAFNA Capital Management LLC 830,538$4,020,0001.51%
Baupost Group 24,471,453$118,442,0001.07%
Nantahala Capital Management 5,789,561$28,021,0000.86%
Old West Investment Management, LLC 367,870$1,780,0000.84%
Abrams Capital Management 5,656,462$27,377,0000.74%
Sofinnova Investments, Inc. 848,356$4,106,0000.38%
Stanley-Laman Group, Ltd. 312,609$1,513,0000.36%
Nantahala Capital Management 2,000,000$9,680,0000.30%
RICE HALL JAMES & ASSOCIATES, LLC 1,494,070$7,231,0000.24%
View complete list of AKEBIA THERAPEUTICS INC shareholders